Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Haypp Group in connection with the listing on Nasdaq First North Growth Market
Mandate

Vinge advises Haypp Group in connection with the listing on Nasdaq First North Growth Market

October 13, 2021 Capital Markets and Public M&A M&A

Vinge advises Haypp Group AB (publ) (“Haypp Group”) in connection with the listing on Nasdaq First North Growth Market. The prospectus was published on 4 October 2021 and the first day of trading on Nasdaq First North Growth Market was 13 October 2021. The offering price was SEK 66 per share, corresponding to a market value of Haypp Group of approximately SEK 1,9 billion.

Haypp Group is an e-commerce business selling nicotine pouches and snus online in nine countries across Europe and in the US. The Company sells a broad selection of brands of any supplier in the category through a range of ten e-commerce platforms and brands, the largest of which is the Swedish snusbolaget.se. Haypp Group was founded in 2009 and is headquartered in Stockholm, Sweden.

The Vinge team mainly includes Christian Lindhé, Erik Sjöman, Kristian Ford (client responsible partner), Martin Svanberg and Johanne Örnfeldt Svensson (Capital Markets and Public M&A) as well as Niklas Törnell and Carl Trolle Olson (M&A).

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025